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a b s t r a c t
In the era of personalized medicine, selecting the ideal treatment modality for head and
neck cancer is becoming more complex. Also, despite the use of the newest agents, overall
survival has not been improved notably over the past few decades. Currently, in accordance
with the development of diagnostic tools, prevention and early detection of cancer are being
emphasized more in obtaining better treatment outcomes. Among the various cancer pre-
ventative methods, the use of green tea is one of the most common approaches, and tea
is known to be involved in multiple steps of carcinogenesis. Thus, in this short review, theeywords:
hemoprevention
reen tea
protective roles of green tea components against the initiation, progression, and metastasis
of head and neck malignancies will be discussed.
© 2014 Korea Institute of Oriental Medicine. Published by Elsevier. This is an open accessead and neck cancer
. Introduction
reen tea, produced from the plant Camellia sinensis, is one of
he most popular beverages in East Asian countries. Recently,
ue to multiple positive effects on various health conditions,
he popularity of green tea has increased further. The com-
onents of green tea include proteins, carbohydrates, lipids,
itamins, caffeine, theophylline, carotenoids, and polyphe-
ols. Among these, polyphenols are the most interesting
onstituent and have become the focus of much biomedical
esearch.
The major polyphenols in green tea are catechins. The
ajor catechins are epigallatocatechin-3-gallate (EGCG), (–)-picatechin-3-gallate (ECG), (-)-epigallatocatechin (EGC), and
–)-epicatechin. Among these, EGCG is the key catechin,
ccounting for up to 80% of the total catechins; a cup of green
ea contains ∼300mg.
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A previous work has demonstrated diverse beneﬁcial
effects of EGCG in Parkinson’s disease, Alzheimer’s disease,
diabetes, stroke, and even obesity.1 In addition to these bene-
ﬁcial properties of EGCG, effects related to cancer prevention
and treatment have been reported.
Because prevention and early detection improve the treat-
ment outcome in every known cancer type, the concept of
“chemoprevention” is becoming more signiﬁcant in cancer
research. Chemoprevention can be deﬁned as the use of
natural or synthetic substances to prevent or suppress the
development, progression, and metastasis of cancer. A repre-
sentative natural product used for chemoprevention of cancer
is EGCG, which has been demonstrated to exert various pos-ity School of Medicine, Woncheon-dong, Yeongtong-gu, Suwon-si,
itive effects on colon, breast, stomach, esophagus, lung, and
prostate cancers and on melanoma.
Head and neck carcinoma, including thyroid cancer, is a
common cancer that remains a signiﬁcant cause of mortality
vier. This is an open access article under the CC BY-NC-ND license
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and devastating morbidity. In the United States, over 48,000
new cases of this carcinoma are diagnosed annually, of whom
more than 10,000 die. Most cases of head and neck cancer are
treated by surgical intervention initially. Owing to the com-
plexity of the anatomical structures in the head and neck
area, complete andwide surgical extirpationof thedisease can
result in severe morbidity, in both functional and esthetical
respects. Althoughmedical and radiation therapies have been
used widely to overcome and compensate for the weak points
and morbidities related to surgery, these conventional treat-
ment modalities have not improved the overall survival rate.
Thus, in accordance with the development of diagnostic
technologies, early detection and prevention of carcinogene-
sis have been emphasized to improve the treatment outcome.
That is, new approaches to cancer management, such as
chemoprevention, should be considered and used to alter the
overall survival rate. Several clinical applications and trials
using natural products such as chemopreventive agents have
demonstrated successful outcomes in terms of preventing
cancer development in high-risk individuals. Here, we review
recent research works on the effects of green tea and discuss
future directions in head and neck cancer prevention.
2. Head and neck squamous cell carcinoma
Among the various cancers of the head and neck, squamous
cell carcinoma (SCC) is the most common. As SCC devel-
opment in this region is associated with different clinical
courses and treatment outcomes according to the primary
site, research outcomes regarding each site should be consid-
ered separately. In terms of themechanisms of action of green
tea components in head and neck SCC, induction of apopto-
sis and growth arrest and inhibition of metastasis are the two
main research foci.
2.1. Oral cavity and pharyngeal cancer
Inducing the apoptotic process is ahighly programmedprotec-
tive mechanism that eliminates damaged cells from the body.
Regarding carcinogenesis, cancer cells, which grow exces-
sively regardless of homeostasis, should be eliminated by
apoptosis. Thus, many previous studies have focused on
enhancing apoptosis by treatment of the oral cavity cancer
and pharyngeal SCC cell lines with green tea components.
The major catechin of green tea, EGCG, has been used in
previous studies related to apoptosis induction.
The simplest work involves evaluation of cell viability and
DNA synthesis levels in green-tea-component-treated oral
squamous cancer cells (SCC-25).2 Dose-dependent and direct
cytotoxic effects of EGCG, ECG, and EGC have been shown.
Inhibition of DNA replicationwas also detected after the treat-
ment.
A cytotoxic effect of EGC in the human squamous cancer-2
cell line has been reported. The focus was on the intracel-
lular reactive oxygen species, hydrogen peroxide, generation
of which increased after EGC treatment compared with the
levels in normal cells. This increased level of hydrogen per-
oxide caused degradation of nucleosomal DNA and induced
caspase-3 activity, which accelerated cell death.3,4Integr Med Res ( 2 0 1 4 ) 11–15
With the exception of these two studies that focused
on direct cytotoxic effects of green tea components, other
research works on the relationship between green tea and
oral cavity/pharyngeal SCC have focused on the modulation
of cell signaling by green tea. Although cytotoxic effects of
EGCG, EGC, and ECG have been reported, only EGCG has been
found to exhibit signaling modulation activity.
Among signaling molecules, cyclin-dependent kinase and
related molecules are the primary targets for EGCG. Expres-
sion of an apoptosis inhibitor and a cyclin-dependent kinase,
p57, were elevated in normal keratinocytes in dose- and
time-dependent manners, whereas the levels in the SCC25
and OSC2 oral carcinoma cell lines were consistent.5 This
expression patternwas correlatedwith the apoptosis status of
treated cells, conﬁrming the chemopreventive effect of EGCG.
Although this report mentioned modulation of apoptosis by
p57, thewhole apoptotic cascadewas not considered. Another
molecule, p21WAF, which plays a role in cell growth, differen-
tiation, and apoptosis, was upregulated in the oral carcinoma
cell line, OSC2, after treatment with EGCG. Using a p21WAF
siRNA, the EGCG-induced overexpression of thismoleculewas
shown to enhance caspase 3-mediated apoptosis.6
Epidermal growth factor receptor (EGFR) is a plasma mem-
brane protein that has an intrinsic tyrosine kinase activity.
A cancer cell phenotype is known to result from the over-
expression of this receptor. As in colon cancer cells, SCC of
the head and neck frequently exhibits upregulation of EGFR
expression.7,8 EGCC treatment of SCC cells ﬁrst results in the
inhibition of EGFR phosphorylation. Afterward, downstream
proteins, such as signal transducer and activator of tran-
scription 3 (Stat3), and extracellular regulated kinase (ERK),
are inhibited sequentially. Other proteins, such as basal and
transforming growth factor--stimulated c-fos and cyclin D1,
were also downregulated, with the consequent signiﬁcant
arrest of cell growth and proliferation.8 Similarly, HER-2/neu
receptor (HER-2), known to be associated with a poor prog-
nosis in patients with breast carcinoma, was modulated by
EGCG in head and neck SCC.9 The working mechanism of
action of EGCG against HER-2 was identical to that against
EGFR. Accordingly, downstream proteins, such as Stat3, c-fos,
cyclin D1, and Bcl-XL were inhibited in order. We also pre-
sented a novel target for chemoprevention using EGCG in head
andneck SCC. Nonsteroidal anti-inﬂammatory drug-activated
gene-1 (NAG-1) is a member of the transforming growth
factor- superfamily, known to be involved in inﬂammation,
apoptosis, and carcinogenesis.10 As the role and mechanism
of NAG-1 in carcinogenesis are controversial, according to
the primary site of the cancers, we focused on determining
the role of this protein in SCC of the head and neck.11–13
EGCG induced NAG-1 expression at the transcriptional level,
which was directly related to EGCG-induced apoptosis in the
KB cell line through caspase-3 activation. We also demon-
strated that ataxia telangiectasia-mutated protein functions
to activate NAG-1, p53, and p21, consequently facilitating
apoptosis. Another strong point of our work was the in vivo
result obtained using an immunocompetent syngeneicmouse
model and intraperitoneal EGCG injection. The results being
identical to those in vitro provided evidence for not only a new
mechanism of head and neck SCC development, but also a
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In addition to the cytotoxic and proapoptotic effects of
reen tea in cancer chemoprevention, inhibition of inva-
ion and metastasis is another research focus. Depending
n the primary site of SCC in the head and neck, such as
he oropharynx and hypopharynx, clinical manifestations
nd subjective symptoms in patients are frequently detected
nly in advanced stages of malignancy. Determination of the
ppropriate treatment strategy for advanced SCC, elimina-
ion of cancer cells, and protection against progression and
etastasis should be performed in combination. Thus, the
ntimetastatic effects of EGCG may become an important
rea of future research. However, relatively few studies have
ddressed the antimetastatic or anti-invasive effects of EGCG
n SCC of the head and neck.
Common targets for modulating metastasis and invasion
n most cancers include matrix metalloproteinase (MMP) and
rokinase-plasminogen activator.14,15 Three previous reports
n the role of EGCG inmetastasis discussMMP and urokinase-
lasminogen activator. MMP-13, also known as collagenase-3,
s known to degrade type IV collagen and various other
xtracellular matrix components. Owing to its proteolytic
ctivity, MMP-13 has been assumed to play a role in cancer
rogression.16 In the oral cavity cancer cell line, the expression
evel ofMMP-13was signiﬁcantly higher than in noncancerous
atched tissue and was downregulated by EGCG treatment.
dditionally, the biological activity of MMP-13 was inhibited
y EGCG treatment.17
Targets of EGCG were also identiﬁed upstream of MMP.
he RECK gene, a tumor suppressor recognized as a negative
egulator of MMP, was demethylated by EGCG treatment and
onsequently inhibited the expression of MMP-2 and MMP-
.18 Due to this inhibition, both the number of invasion foci
nd the invasion depthwere decreased in a three-dimensional
ollagen invasion model.18 A different approach to determin-
ng the antimetastatic effect of EGCG in oral cavity cancer
as reported by Chen et al.19 They focused on the epithelial-
o-mesenchymal transition, which is a critical process in
pithelial-origin cancer metastasis. Expression of proteins
elated with epithelial-to-mesenchymal transition, such as
-focal adhesion kinase, p-Src, snail-1, and vimentin, were
ecreasedmarkedly after treatment of the SCC-9 cell linewith
GCG.
Our study of the antimetastatic effects of EGCG in the
ral cavity cancer demonstrated that hepatocyte growth factor
HGF) and its receptor c-Met protein have a close relationship
ith cancer invasion.20–22 Inhibiting HGF-induced phosphory-
ation of c-Met in vitro by EGCG decreased MMP-2 and MMP-9,
hich accounted for the antimetastatic effect. The down-
tream signal transduction pathway of c-Met was revealed,
nd the AKT and ERK proteinswere found to be involved. Inhi-
ition of these proteins was associated with activation of p38,
NK, caspase-3, and PARP. Translating this in vitro result into
n in vivo system resulted in an identical outcome. Inhibition
f HGF may be a therapeutic target for preventing oral cavity
ancer cell metastasis and invasion.
Despite the evidence of the positive effects of green tea
omponents, many are curious about the protective effect
hat can be achieved simply by drinking green tea. This was
nvestigated in a large Japanese cohort study.23 In total, 20,550
ales and 29,671 females, aged 40–79 years, were included13
and observed for an average of 10.3 years. Prior to the analy-
sis, age andother etiological factors associatedwith oral cavity
and pharyngeal carcinogenesis were adjusted. Interestingly,
only females who consumed green tea showed a reduced risk
of cancer, whereas males apparently did not gain any advan-
tage from its consumption. This result is inconsistent with
much research data and reﬂects the need for further research,
outcome accumulation, and clinical trials.
2.2. Laryngeal cancers
Compared with oral cavity and pharyngeal SCC, studies of
laryngeal SCC are relatively rare. Speciﬁc studies on laryngeal
cells were mentioned only in four articles, each of which had
a different focus. Durgo et al24 attempted to increase the sen-
sitivity to cisplatin of the laryngeal cancer cell line, CK2, using
EGCG and ECG. EGCG and ECG treatment caused DNA damage
and lipid peroxidation in cancer cells.
Telomerase was another target in laryngeal cancer, which
had not been investigated in oral cavity or pharyngeal
cancers.25 Most normal somatic cells have very low or no tel-
omerase activity. Additionally, the telomerase holoenzyme,
human telomerase reverse transcriptase (hTERT), is expressed
in cancer cells, including laryngeal SCC. Inhibition of this
enzyme protects against cancer cell proliferation and malig-
nant transformation of normal cells.26,27
Treatment of a laryngeal SCC cell line with EGCG resulted
in the inhibition of telomerase and hTERT activities, induc-
ing apoptosis.25 One common apoptotic pathway involves
caspase-3 activation in cancer cells; this mechanism has been
reported to be active in laryngeal SCCcells.25 However, another
article reported that EGCG-induced apoptosis in laryngeal SCC
proceeded through a caspase-independent pathway, involving
a p53-mediated mitochondrial pathway and nuclear translo-
cation of apoptosis-inducing factor and endonuclease G.28
These seemingly contradictory results suggest the possibil-
ity ofmultiple effects of EGCG in cancer cell apoptosis; indeed,
themechanismmay differ among cell types. As no single type
of cancer is treatedwith a single therapeutic agent ormodality,
novel research on the combined usage of the natural prod-
ucts curcumin and catechin shows promise.29 Treatment of
HepG2 cells and laryngeal SCC with this combination exerted
a greater cytotoxic effect than either agent alone.
2.3. Thyroid cancers
Thyroid cancer is a common malignancy of the head and
neck area that can be treated successfully with surgery and
radioiodine therapy. Most are well-differentiated carcinomas
(papillary and follicular cancers), with favorable prognoses
after initial treatment. The problem develops when they recur
or metastasize. No relationship between green tea and well-
differentiated thyroid cancer has been reported; in fact, the
ﬁrst in vitro research was reported only recently. This study
used human thyroid carcinoma cell lines and focused on
inhibition of metastasis and invasion.30 EGCG inhibited the
growth of papillary (FB-2) and follicular (WRO) cell lines by
a mechanism involving cyclin D1, p21, and p53. Also, cellu-
lar migration of FB-2 was modulated by EGCG, in association
with the downregulation of vimentin, E- and N-cadherin, and
r14
alpha-5 integrin. That is, EGCG inhibited growth and metasta-
sis of well-differentiated carcinoma cells. Anaplastic thyroid
carcinoma is an uncommon pathology of the thyroid with a
very poor prognosis, due in part to the lack of a deﬁnite treat-
ment. Green teamay have an effect in this case, because EGCG
was found to have proapoptotic effects in the report by Lim
and Cha.31 Apoptosis in anaplastic thyroid carcinoma cells
was associated with inhibition of EGF, ERK1/2, JNK, and p38
phosphorylation; reduced cyclin B1/CDK1 expression; accu-
mulation of sub-G1 cells; and caspase-3 pathway activation.
Similar to the oral cavity and pharyngeal SCC study
mentioned above, a Japanese population-based cohort study
reported the relation between green tea consumption and thy-
roid cancer risk.32 In total, 48,802 males and 51,705 females,
with ages ranging from 40 years to 69 years, were enrolled
and observed for a median of 14.2 years. The development of
thyroid malignancy was noted in 159 cases, but no signiﬁcant
association was found in general. However, a positive corre-
lation was noted between premenopausal thyroid cancer risk
and green tea consumption, whereas postmenopausal thyroid
cancer risk showed an inverse association.
3. Future considerations and conclusions
Selecting the most appropriate treatment in head and neck
SCC is a difﬁcult task for clinicians because these tumors are
usually detected at an advanced stage, resulting in poor out-
comes. To overcome the limitations of current treatments,
there is a continuing need for a therapeutic agent with high
efﬁcacy, safety, and minimal toxicity. Thus, natural dietary
agents have become a focus in cancer research because they
may hold particular promise. Among them, a green tea com-
ponent, EGCG,may be the singlemost important agent, which
has demonstrated positive effects in preventing and treat-
ing head and neck cancers. EGCC protects against diverse
steps in cancer progression and invasion throughmultiple and
complex signal transduction pathways. However, most of the
research outcomes to date are derived from cell lines and so
do not provide evidence of in vivo efﬁcacy. Also, the differences
between concentrations in plasma and in in vitro culture sys-
temsmake the evaluation of the efﬁcacy of EGCG problematic.
Thus, progress is needed in the following three areas prior
to considering the clinical application of green tea. First, fur-
ther understanding of the signaling pathways and molecules
is indispensable for the development of EGCG-derived thera-
peutic agents. Second, integration of in vitro outcomes, in vivo
animal model studies, and human clinical trials is needed. As
we have stated here, only a few animal studies and clinical
trials on head and neck SCC treatment with EGCG have been
carried out. Finally, after these two tasks are carried out, the
formulation and contents of green tea components should be
standardized prior to its clinical assessment.Conﬂicts of interest
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